Comparison of cancer risk estimates based on a variety of risk assessment methodologies

被引:18
作者
Gold, LS
Gaylor, DW
Slone, TH
机构
[1] Lawrence Berkeley Natl Lab, Berkeley, CA 94720 USA
[2] Univ Calif Berkeley, Berkeley, CA 94720 USA
[3] Sci Int Inc, Little Rock, AR 72212 USA
关键词
D O I
10.1016/S0273-2300(02)00026-0
中图分类号
DF [法律]; D9 [法律]; R [医药、卫生];
学科分类号
0301 ; 10 ;
摘要
The EPA guidelines recommend a benchmark dose as a point of departure (PoD) for low-dose cancer risk assessment. Generally the PoD is the lower 95% confidence limit on the dose estimated to produce an extra lifetime cancer risk of 10% (LTD10). Due to the relatively narrow range of doses in two-year bioassays and the limited range of statistically significant tumor incidence rates, the estimate of the LTD10 is constrained to a relatively narrow range of values. Because of this constraint, simple, quick estimates of the LTD10 can be readily obtained for hundreds of rodent carcinogens from the Carcinogenic Potency Database (CPDB) of Gold et al. Three estimation. procedures for LTD10 are described, using increasing information from the CPDB: (A) based on only the maximum tolerated dose (the highest dose tested); (B) based on the TD50; and (C) based on the TD50 and its lower 99% confidence limit. As expected, results indicate overall similarity of the LTD10 estimates and the value of using additional information. For Method (C) the estimator based on the [{(TD50)(0.36) x (LoConf)(0.64)}/6.6] is generally similar to the estimator based on the one-hit model or multistage model LTD10. This simple estimate of the LTD10 is applicable for both linear and curved dose responses with high or low background tumor rates, and whether the confidence limits on the TD50 are wide or tight. The EPA guidelines provide for a margin of exposure approach if data are sufficient to support a nonlinear dose-response. The reference dose for cancer for a nonlinear dose-response curve based on a 10,000-fold uncertainty (safety) factor from the LTD10, i.e., the LTD10/10,000, is mathematically equivalent to the value for a linear extrapolation from the LTD10 to the dose corresponding to a cancer risk of <10(-5) (LTD10/10,000). The cancer risk at <10(-5) obtained by using the q*(l) from the multistage model, is similar to LTD10/10,000. For a nonlinear case, an uncertainty factor of less than 10,000 is likely to be used, which would result in a higher (less stringent) acceptable exposure level. (C) 2003 Elsevier Science (USA). All rights reserved.
引用
收藏
页码:45 / 53
页数:9
相关论文
共 23 条
[1]   Paracelsus to parascience: the environmental cancer distraction [J].
Ames, BN ;
Gold, LS .
MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS, 2000, 447 (01) :3-13
[2]  
[Anonymous], HUMAN ECOLOGICAL RIS, DOI [10.1080/10807 039509380044, DOI 10.1080/10807039509380044]
[3]   REFERENCE DOSE (RFD) - DESCRIPTION AND USE IN HEALTH RISK ASSESSMENTS [J].
BARNES, DG ;
DOURSON, M .
REGULATORY TOXICOLOGY AND PHARMACOLOGY, 1988, 8 (04) :471-486
[4]   SOME TAUTOLOGOUS ASPECTS OF THE COMPARISON OF CARCINOGENIC POTENCY IN RATS AND MICE [J].
BERNSTEIN, L ;
GOLD, LS ;
AMES, BN ;
PIKE, MC ;
HOEL, DG .
FUNDAMENTAL AND APPLIED TOXICOLOGY, 1985, 5 (01) :79-86
[5]   UNCERTAINTY IN CANCER RISK ESTIMATES [J].
GAYLOR, DW ;
CHEN, JJ ;
SHEEHAN, DM .
RISK ANALYSIS, 1993, 13 (02) :149-154
[6]   RELATIONSHIP BETWEEN THE SHAPE OF DOSE-RESPONSE CURVES AND BACKGROUND TUMOR RATES [J].
GAYLOR, DW .
REGULATORY TOXICOLOGY AND PHARMACOLOGY, 1992, 16 (01) :2-9
[7]   QUICK ESTIMATE OF THE REGULATORY VIRTUALLY SAFE DOSE BASED ON THE MAXIMUM TOLERATED DOSE FOR RODENT BIOASSAYS [J].
GAYLOR, DW ;
GOLD, LS .
REGULATORY TOXICOLOGY AND PHARMACOLOGY, 1995, 22 (01) :57-63
[8]   Regulatory cancer risk assessment based an a quick estimate of a benchmark dose derived from the maximum tolerated dose [J].
Gaylor, DW ;
Gold, LS .
REGULATORY TOXICOLOGY AND PHARMACOLOGY, 1998, 28 (03) :222-225
[9]  
Gold LS, 1999, ENVIRON HEALTH PERSP, V107, P527
[10]   What do animal cancer tests tell us about human cancer risk? Overview of analyses of the carcinogenic potency database [J].
Gold, LS ;
Slone, TH ;
Ames, BN .
DRUG METABOLISM REVIEWS, 1998, 30 (02) :359-404